VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

CUSIP: 921937819

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / INTERMED TERM
Total 13F shares
222,777,189
Share change
+12,694,774
Total reported value
$17,344,019,720
Price per share
$77.88
Number of holders
973
Value change
+$988,071,551
Number of buys
554
Number of sells
301

Security key

921937819

Report period

Q4 2025

Institutions

973

Top holders

10

Ownership snapshot

Top shareholders of BIV - VANGUARD BD INDEX FDS - INTERMED TERM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
973
Shares
222,777,189
Rows loaded
975
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
917
Q4 2025 holders
973
Holder diff
56
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .